Cargando…

Does Percutaneous Lumbosacral Pedicle Screw Instrumentation Prevent Long-Term Adjacent Segment Disease after Lumbar Fusion?

STUDY DESIGN: Retrospective cohort study. PURPOSE: To assess long-term clinical outcomes of adjacent segment disease (ASD) in patients who underwent lumbar interbody fusion with percutaneous pedicle screw (PS) instrumentation. OVERVIEW OF LITERATURE: ASD is a well-known sequela of spinal fusion, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Changoor, Stuart, Faloon, Michael Joseph, Dunn, Conor John, Sahai, Nikhil, Issa, Kimona, Sinha, Kumar, Hwang, Ki Soo, Emami, Arash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Spine Surgery 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217847/
https://www.ncbi.nlm.nih.gov/pubmed/32872750
http://dx.doi.org/10.31616/asj.2020.0157
_version_ 1783710675949846528
author Changoor, Stuart
Faloon, Michael Joseph
Dunn, Conor John
Sahai, Nikhil
Issa, Kimona
Sinha, Kumar
Hwang, Ki Soo
Emami, Arash
author_facet Changoor, Stuart
Faloon, Michael Joseph
Dunn, Conor John
Sahai, Nikhil
Issa, Kimona
Sinha, Kumar
Hwang, Ki Soo
Emami, Arash
author_sort Changoor, Stuart
collection PubMed
description STUDY DESIGN: Retrospective cohort study. PURPOSE: To assess long-term clinical outcomes of adjacent segment disease (ASD) in patients who underwent lumbar interbody fusion with percutaneous pedicle screw (PS) instrumentation. OVERVIEW OF LITERATURE: ASD is a well-known sequela of spinal fusion, and is reported to occur at a rate of 2%–3% per year. There is debate as to whether ASD is a result of the instrumentation and fusion method or is the natural history of the patient’s disease. Minimally invasive percutaneous PS augmentation of lumbar interbody fusion aims to prevent the disruption of posterior soft tissue stabilizers. METHODS: From 2004–2014, 419 consecutive patients underwent anterior, lateral, or minimally invasive transforaminal lumbar interbody fusion with percutaneous PS placement at a single institution. The mean follow-up was 4.5 years. The primary outcome measure was reoperation due to ASD. Patients were divided into two cohorts: those who underwent revision surgery secondary to ASD and those who did not require further surgery. Radiographic parameters were performed using postoperative radiographs. Patients with a pelvic incidence–lumbar lordosis (PI–LL) mismatch >10° were noted. RESULTS: Revision proportion secondary to ASD was 4.77% (n=20). Mean time to revision surgery was 2.5 years. Revision rate secondary to ASD was 1.1% per year. Patients who developed ASD were younger than those who did not (50.5 vs. 56.9 years, p=0.015). There was no difference in number of levels fused between cohorts. Revision proportion secondary to ASD was similar between approaches (anterior, lateral, minimally invasive). There was no significant difference in PI–LL mismatch between those who underwent revision for ASD and those who did not (22.2% vs. 18.8%, p=0.758). CONCLUSIONS: ASD rates in patients who underwent percutaneous PS placement were lower than those previously published after open PS placement, possibly related to greater preservation of the posterior stabilizing elements of the lumbar spine.
format Online
Article
Text
id pubmed-8217847
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Korean Society of Spine Surgery
record_format MEDLINE/PubMed
spelling pubmed-82178472021-07-02 Does Percutaneous Lumbosacral Pedicle Screw Instrumentation Prevent Long-Term Adjacent Segment Disease after Lumbar Fusion? Changoor, Stuart Faloon, Michael Joseph Dunn, Conor John Sahai, Nikhil Issa, Kimona Sinha, Kumar Hwang, Ki Soo Emami, Arash Asian Spine J Clinical Study STUDY DESIGN: Retrospective cohort study. PURPOSE: To assess long-term clinical outcomes of adjacent segment disease (ASD) in patients who underwent lumbar interbody fusion with percutaneous pedicle screw (PS) instrumentation. OVERVIEW OF LITERATURE: ASD is a well-known sequela of spinal fusion, and is reported to occur at a rate of 2%–3% per year. There is debate as to whether ASD is a result of the instrumentation and fusion method or is the natural history of the patient’s disease. Minimally invasive percutaneous PS augmentation of lumbar interbody fusion aims to prevent the disruption of posterior soft tissue stabilizers. METHODS: From 2004–2014, 419 consecutive patients underwent anterior, lateral, or minimally invasive transforaminal lumbar interbody fusion with percutaneous PS placement at a single institution. The mean follow-up was 4.5 years. The primary outcome measure was reoperation due to ASD. Patients were divided into two cohorts: those who underwent revision surgery secondary to ASD and those who did not require further surgery. Radiographic parameters were performed using postoperative radiographs. Patients with a pelvic incidence–lumbar lordosis (PI–LL) mismatch >10° were noted. RESULTS: Revision proportion secondary to ASD was 4.77% (n=20). Mean time to revision surgery was 2.5 years. Revision rate secondary to ASD was 1.1% per year. Patients who developed ASD were younger than those who did not (50.5 vs. 56.9 years, p=0.015). There was no difference in number of levels fused between cohorts. Revision proportion secondary to ASD was similar between approaches (anterior, lateral, minimally invasive). There was no significant difference in PI–LL mismatch between those who underwent revision for ASD and those who did not (22.2% vs. 18.8%, p=0.758). CONCLUSIONS: ASD rates in patients who underwent percutaneous PS placement were lower than those previously published after open PS placement, possibly related to greater preservation of the posterior stabilizing elements of the lumbar spine. Korean Society of Spine Surgery 2021-06 2020-09-03 /pmc/articles/PMC8217847/ /pubmed/32872750 http://dx.doi.org/10.31616/asj.2020.0157 Text en Copyright © 2021 by Korean Society of Spine Surgery https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Changoor, Stuart
Faloon, Michael Joseph
Dunn, Conor John
Sahai, Nikhil
Issa, Kimona
Sinha, Kumar
Hwang, Ki Soo
Emami, Arash
Does Percutaneous Lumbosacral Pedicle Screw Instrumentation Prevent Long-Term Adjacent Segment Disease after Lumbar Fusion?
title Does Percutaneous Lumbosacral Pedicle Screw Instrumentation Prevent Long-Term Adjacent Segment Disease after Lumbar Fusion?
title_full Does Percutaneous Lumbosacral Pedicle Screw Instrumentation Prevent Long-Term Adjacent Segment Disease after Lumbar Fusion?
title_fullStr Does Percutaneous Lumbosacral Pedicle Screw Instrumentation Prevent Long-Term Adjacent Segment Disease after Lumbar Fusion?
title_full_unstemmed Does Percutaneous Lumbosacral Pedicle Screw Instrumentation Prevent Long-Term Adjacent Segment Disease after Lumbar Fusion?
title_short Does Percutaneous Lumbosacral Pedicle Screw Instrumentation Prevent Long-Term Adjacent Segment Disease after Lumbar Fusion?
title_sort does percutaneous lumbosacral pedicle screw instrumentation prevent long-term adjacent segment disease after lumbar fusion?
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217847/
https://www.ncbi.nlm.nih.gov/pubmed/32872750
http://dx.doi.org/10.31616/asj.2020.0157
work_keys_str_mv AT changoorstuart doespercutaneouslumbosacralpediclescrewinstrumentationpreventlongtermadjacentsegmentdiseaseafterlumbarfusion
AT faloonmichaeljoseph doespercutaneouslumbosacralpediclescrewinstrumentationpreventlongtermadjacentsegmentdiseaseafterlumbarfusion
AT dunnconorjohn doespercutaneouslumbosacralpediclescrewinstrumentationpreventlongtermadjacentsegmentdiseaseafterlumbarfusion
AT sahainikhil doespercutaneouslumbosacralpediclescrewinstrumentationpreventlongtermadjacentsegmentdiseaseafterlumbarfusion
AT issakimona doespercutaneouslumbosacralpediclescrewinstrumentationpreventlongtermadjacentsegmentdiseaseafterlumbarfusion
AT sinhakumar doespercutaneouslumbosacralpediclescrewinstrumentationpreventlongtermadjacentsegmentdiseaseafterlumbarfusion
AT hwangkisoo doespercutaneouslumbosacralpediclescrewinstrumentationpreventlongtermadjacentsegmentdiseaseafterlumbarfusion
AT emamiarash doespercutaneouslumbosacralpediclescrewinstrumentationpreventlongtermadjacentsegmentdiseaseafterlumbarfusion